IOVA - Iovance Biotherapeutics GAAP EPS of -$0.46 misses by $0.01
2023-11-07 16:14:14 ET
More on Iovance Biotherapeutics
- Iovance Biotherapeutics: Testing Shareholders' Patience
- Iovance Biotherapeutics: Good Trade Setup Created By The FDA Delay Gets Even Better
- Iovance Biotherapeutics: Navigates Regulatory Delays With Strategic Finesse (Rating Upgrade)
- Iovance Biotherapeutics Q3 2023 Earnings Preview
- Iovance director discloses purchase of 5M shares
For further details see:
Iovance Biotherapeutics GAAP EPS of -$0.46 misses by $0.01